Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation

Clinical trial NCT05737706 · TERMINATED

Trial details

NCT number: NCT05737706
Sponsor: Mirati Therapeutics Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Advanced Solid Tumor Non-small Cell Lung Cancer Colo-rectal Cancer Pancreatic Adenocarcinoma

Start date: 2023-03-06
Primary completion: 2025-03-10
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.